EPO Patents = 2

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Silas Bond (3 out of 3 patents)

Penelope Jane Huggins (3 out of 3 patents)

Jack Gordon Parsons (3 out of 3 patents)

4. Luisa Diomede (1 out of 1 patent)

5. Mario Salmona (1 out of 3 patents)

6. Giampaolo Merlini (1 out of 1 patent)

7. Kevin Jeffrey Barnham (11 patents)

8. Antony Vincent Robinson (3 patents)

9. Elisabeth Colette Louise Gautier (0 patent)

4 patents: Sort by Forward Citations

1. 11603364 - Acyl hydrazone derivative compounds for treating disease (2023-03-14),

2. 11357770 - Method of treating immunoglobulin light chain amyloidosis (2022-06-14),

3. 11155547 - Compounds for and methods of treating diseases (2021-10-26),

4. 10941143 - Imidazo [1,5-a]pyridine compounds and their use (2021-03-09),

Alterity Therapeutics Limited is a biotechnology company focused on developing novel therapeutics for the treatment of neurodegenerative diseases. The company's lead drug candidate, PBT434, is currently in clinical trials for the potential treatment of Parkinson's disease and other neurological disorders. Alterity Therapeutics is dedicated to advancing innovative treatments that have the potential to positively impact patient lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#39 in Melbourne

#982 in Australia

Melbourne, Australia

Alterity Therapeutics Limited